ScreenerHero
ENZYEnzymatica AB
STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · enzymatica.com
1.900SEK-1.30%Mkt Cap: 44.69M $P/E: —

Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that ca…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap44.69M $
Enterprise Value44.79M $
Revenue (TTM)4.97M $
Gross Profit3.17M $
Net Income (TTM)-4.96M $
Revenue/Share0.0205 USD
Last Price1.900 SEK
Fiscal Year EndMar 2021
MR QuarterJun 2026
Employees18
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0003943620
Valuation
P/E (Trailing)—
P/E (Forward)-6.38
PEG—
EV/EBITDA-11.08
EV/Revenue9.02
P/S8.95
P/B4.73
EPS (TTM)-0.19
EPS (Forward)-0.30
52W Range
1.60017% of range3.400
52W High3.400 SEK
52W Low1.600 SEK
Profitability
Gross Margin61.45%
Oper. Margin-176.83%
EBITDA Margin-81.39%
Profit Margin-96.27%
ROE-41.79%
ROA-36.55%
Growth
Revenue Growth-13.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.92M $
CapEx (TTM)22.10K $
FCF Margin-27.64%
FCF Yield-3.07%
Net Debt97.76K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.01
Current Ratio2.45
Quick Ratio1.48
Book Value/Sh0.4050 SEK
Cash/Share0.0540 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.242.74M
Float103.87M
Insiders63.16%
Institutions9.85%
Technical
SMA 502.184 (-13.0%)
SMA 2002.223 (-14.5%)
Beta-0.40
S&P 52W Chg18.16%
Avg Vol (30d)75.06K
Avg Vol (10d)65.80K
Technical Indicators
RSI (14)41.8
MACD-0.0785
MACD Signal-0.1078
MACD Hist.+0.0294
BB Upper2.008 SEK
BB Middle1.895 SEK
BB Lower1.781 SEK
BB Width11.98%
ATR (14)0.1245 SEK
Vol Ratio (20d)0.13x